BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 26978355)

  • 1. Molecular Selection, Modification and Development of Therapeutic Oligonucleotide Aptamers.
    Yu Y; Liang C; Lv Q; Li D; Xu X; Liu B; Lu A; Zhang G
    Int J Mol Sci; 2016 Mar; 17(3):358. PubMed ID: 26978355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamers as Therapeutic Agents: Has the Initial Euphoria Subsided?
    Haßel SK; Mayer G
    Mol Diagn Ther; 2019 Jun; 23(3):301-309. PubMed ID: 31037641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamers: from bench side research towards patented molecules with therapeutic applications.
    Majumder P; Gomes KN; Ulrich H
    Expert Opin Ther Pat; 2009 Nov; 19(11):1603-13. PubMed ID: 19852719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleic acid-based aptamers: applications, development and clinical trials.
    Kanwar JR; Roy K; Maremanda NG; Subramanian K; Veedu RN; Bawa R; Kanwar RK
    Curr Med Chem; 2015; 22(21):2539-57. PubMed ID: 25723512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamers in hematological malignancies and their potential therapeutic implications.
    Ouyang W; Yu Z; Zhao X; Lu S; Wang Z
    Crit Rev Oncol Hematol; 2016 Oct; 106():108-17. PubMed ID: 27637356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes.
    Ni S; Yao H; Wang L; Lu J; Jiang F; Lu A; Zhang G
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28767098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aptamer therapeutics advance.
    Lee JF; Stovall GM; Ellington AD
    Curr Opin Chem Biol; 2006 Jun; 10(3):282-9. PubMed ID: 16621675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotide aptamers for glioma targeting: an update.
    Camorani S; Cerchia L
    Cent Nerv Syst Agents Med Chem; 2015; 15(2):126-37. PubMed ID: 25924917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA aptamers: a review of recent trends and applications.
    Kang KN; Lee YS
    Adv Biochem Eng Biotechnol; 2013; 131():153-69. PubMed ID: 22491855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in aptamers.
    Syed MA; Pervaiz S
    Oligonucleotides; 2010 Oct; 20(5):215-24. PubMed ID: 20677985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications.
    Ni S; Zhuo Z; Pan Y; Yu Y; Li F; Liu J; Wang L; Wu X; Li D; Wan Y; Zhang L; Yang Z; Zhang BT; Lu A; Zhang G
    ACS Appl Mater Interfaces; 2021 Mar; 13(8):9500-9519. PubMed ID: 32603135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of aptamers in medicine.
    Khati M
    J Clin Pathol; 2010 Jun; 63(6):480-7. PubMed ID: 20360137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the Uncertain Future of Aptamer-Based Diagnostics and Therapeutics.
    Bruno JG
    Molecules; 2015 Apr; 20(4):6866-87. PubMed ID: 25913927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of aptamer oligonucleotides as anticoagulants and antithrombotics for cardiovascular diseases: current status.
    Li W; Wang K; Zhao M; Yang X; Chen M; Lan X
    Thromb Res; 2014 Oct; 134(4):769-73. PubMed ID: 25113995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamers as promising molecular recognition elements for diagnostics and therapeutics in the central nervous system.
    McConnell EM; Holahan MR; DeRosa MC
    Nucleic Acid Ther; 2014 Dec; 24(6):388-404. PubMed ID: 25296265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleic acid aptamers: clinical applications and promising new horizons.
    Ni X; Castanares M; Mukherjee A; Lupold SE
    Curr Med Chem; 2011; 18(27):4206-14. PubMed ID: 21838685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic applications of synthetic nucleic acid aptamers.
    Poolsup S; Kim CY
    Curr Opin Biotechnol; 2017 Dec; 48():180-186. PubMed ID: 28582756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamers: Potential Diagnostic and Therapeutic Agents for Blood Diseases.
    Aljohani MM; Cialla-May D; Popp J; Chinnappan R; Al-Kattan K; Zourob M
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic aptamers: developmental potential as anticancer drugs.
    Lee JW; Kim HJ; Heo K
    BMB Rep; 2015 Apr; 48(4):234-7. PubMed ID: 25560701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.